Eli Lilly said preliminary data from a late-stage study showed its weight-loss drug significantly reduced the risk of progression to type 2 diabetes among adults with prediabetes and obesity or overweight.
Related Posts
Elon Musk’s $46 Billion Pay Package: How Tesla Shareholder Approval Could Play Out in Court
- staff
- June 13, 2024
- 0
The carmaker’s CEO says so far, shareholders were approving the package by a wide margin. But a vote to reapprove the agreement is unlikely to […]
Tesla Reports Higher Profit in Third Quarter
The surprise increase was the first since the electric-car maker’s earnings began to slide earlier this year as it turned to deep price cuts and […]
Boeing Gets Flurry of Orders at International Airshow
Boeing received orders for up to 70 airplanes at the Farnborough International Airshow, marking a much-needed show of confidence in the embattled plane maker.